BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 12055259)

  • 1. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
    Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
    J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
    Williams L; Bradley L; Smith A; Foxwell B
    J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
    Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
    J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10.
    Crepaldi L; Gasperini S; Lapinet JA; Calzetti F; Pinardi C; Liu Y; Zurawski S; de Waal Malefyt R; Moore KW; Cassatella MA
    J Immunol; 2001 Aug; 167(4):2312-22. PubMed ID: 11490020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.
    Cassatella MA; Gasperini S; Bovolenta C; Calzetti F; Vollebregt M; Scapini P; Marchi M; Suzuki R; Suzuki A; Yoshimura A
    Blood; 1999 Oct; 94(8):2880-9. PubMed ID: 10515892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages.
    Qasimi P; Ming-Lum A; Ghanipour A; Ong CJ; Cox ME; Ihle J; Cacalano N; Yoshimura A; Mui AL
    J Biol Chem; 2006 Mar; 281(10):6316-24. PubMed ID: 16352613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
    Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
    Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
    J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Delgado M; Ganea D
    J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling.
    Jackson SH; Yu CR; Mahdi RM; Ebong S; Egwuagu CE
    J Immunol; 2004 Feb; 172(4):2307-15. PubMed ID: 14764699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
    Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma.
    Stoiber D; Kovarik P; Cohney S; Johnston JA; Steinlein P; Decker T
    J Immunol; 1999 Sep; 163(5):2640-7. PubMed ID: 10453004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW; Chang YH; Tsi CJ; Lin WW
    J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.
    Medvedev AE; Kopydlowski KM; Vogel SN
    J Immunol; 2000 Jun; 164(11):5564-74. PubMed ID: 10820230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-alpha production.
    Nishiki S; Hato F; Kamata N; Sakamoto E; Hasegawa T; Kimura-Eto A; Hino M; Kitagawa S
    Am J Physiol Cell Physiol; 2004 Jun; 286(6):C1302-11. PubMed ID: 14736711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3.
    Stoiber D; Stockinger S; Steinlein P; Kovarik J; Decker T
    J Immunol; 2001 Jan; 166(1):466-72. PubMed ID: 11123325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
    Morrison AC; Wilson CB; Ray M; Correll PH
    J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
    Carl VS; Gautam JK; Comeau LD; Smith MF
    J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.